The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of trametinib and neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC) that harbor KRAS, BRAF, or NRAS mutations.
 
Christina Sing-Ying Wu
Consulting or Advisory Role - Bayer
Research Funding - Amgen
 
Terence Marques Williams
No Relationships to Disclose
 
Lai Wei
No Relationships to Disclose
 
Hamida Umar
No Relationships to Disclose
 
Arsen Savysan
No Relationships to Disclose
 
Sameh Mikhail
Consulting or Advisory Role - Bayer; bioTheranostics; Boehringer Ingelheim; Perthera
Travel, Accommodations, Expenses - Celgene
 
Kristen Keon Ciombor
Research Funding - Boston Biomedical; MedImmune; Pfizer
 
Anne M. Noonan
Consulting or Advisory Role - Helsinn Healthcare
 
Sameek Roychowdhury
No Relationships to Disclose
 
Samer S El-Dika
No Relationships to Disclose
 
Somashekar Krishna
No Relationships to Disclose
 
Bennie Upchurch
No Relationships to Disclose
 
Mark Arnold
No Relationships to Disclose
 
Alan Harzman
No Relationships to Disclose
 
Sherif Abdel-Misih
No Relationships to Disclose
 
William Cirocco
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly; NCCN; Pfizer; Regeneron; Research to Practice; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Polaris
 
Evan John Wuthrick
Research Funding - Bristol-Myers Squibb